NKG2Cpos NK Cells Regulate the Expansion of Cytomegalovirus-Specific CD8 T Cells

J Immunol. 2020 Jun 1;204(11):2910-2917. doi: 10.4049/jimmunol.1901281. Epub 2020 Apr 13.

Abstract

Infection with the human CMV associates with phenotypic alterations in lymphocyte subsets. A highly reproducible finding in CMV-seropositive individuals is an expansion of NKG2Cpos NK cells. In this study, we analyzed if the altered NK cell compartment in CMV-seropositive human donors may affect CMV-specific CD8 T cells. Resting CMV-specific CD8 T cells were terminally differentiated and expressed high levels of the NKG2C ligand HLA-E. Activation of CMV-specific CD8 T cells with the cognate Ag further increased HLA-E expression. In line with a negative regulatory effect of NKG2Cpos NK cells on HLA-Ehigh CD8 T cells, depletion of NKG2Cpos NK cells enhanced Ag-specific expansion of CMV-specific CD8 T cells in vitro. In turn, the activation of NK cells in coculture with CMV-specific CD8 T cells promoted a selective loss of HLA-Ehigh CD8 T cells. To test if NKG2Cpos NK cells can target HLA-Ehigh CD8 T cells, Jurkat T cells with and without stabilized HLA-E on the surface were used. NKG2Cpos NK cells stimulated with HLA-Ehigh Jurkat cells released higher levels of Granzyme B compared with NKG2Cneg NK cells and NKG2Cpos NK cells stimulated with HLA-Elow Jurkat cells. Moreover, intracellular levels of caspase 3/7 were increased in HLA-Ehigh Jurkat cells compared with HLA-Elow Jurkat cells, consistent with higher rates of apoptosis in HLA-Ehigh T cells in the presence of NKG2Cpos NK cells. Our data show that NKG2Cpos NK cells interact with HLA-Ehigh CD8 T cells, which may negatively regulate the expansion of CMV-specific CD8 T cells upon activation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Animals
  • Apoptosis
  • CD8-Positive T-Lymphocytes / immunology*
  • Cytomegalovirus / physiology*
  • Cytomegalovirus Infections / immunology*
  • HLA-E Antigens
  • Histocompatibility Antigens Class I / metabolism
  • Humans
  • Jurkat Cells
  • Killer Cells, Natural / immunology*
  • Mice
  • Middle Aged
  • NK Cell Lectin-Like Receptor Subfamily C / metabolism
  • T-Lymphocytes / immunology*
  • Young Adult

Substances

  • Histocompatibility Antigens Class I
  • KLRC2 protein, human
  • NK Cell Lectin-Like Receptor Subfamily C